Correction to: Population pharmacokinetics‑pharmacodynamics of fondaparinux in dialysis‑dependent chronic kidney disease patients undergoing chronic renal replacement therapy
Eur J Clin Pharmacol
.
2022 Jan;78(1):99.
doi: 10.1007/s00228-021-03220-y.
Authors
Danica Michaličková
1
,
Jan Miroslav Hartinger
2
,
Zuzana Hladinová
3
,
Vladimíra Bednářová
3
,
Barbora Szonowská
4
,
Vladimír Polakovič
4
,
Andreas Matthios
2
5
,
Vladimír Tesař
,
Ondřej Slanař
2
,
Elke H J Krekels
6
Affiliations
1
Institute of Pharmacology, First Faculty of Medicine &, General University Hospital, Charles University, Prague, Czech Republic. marrtta@gmail.com.
2
Institute of Pharmacology, First Faculty of Medicine &, General University Hospital, Charles University, Prague, Czech Republic.
3
Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
4
Internal Department of Strahov, General University Hospital, Prague, Czech Republic.
5
Department of Biophysics and Physical Chemistry, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic.
6
Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands.
PMID:
34528123
DOI:
10.1007/s00228-021-03220-y
No abstract available
Publication types
Published Erratum